Related Experiment Video
Updated: Jun 5, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Citrullinaemia type I: a common mutation in the Pacific Island population
Emma Glamuzina1, Renate Marquis-Nicholson, Detlef Knoll
1Paediatric Metabolic Service, Starship Children's Hospital, Auckland, New Zealand.
Insights
A new ASS1 gene mutation screening protocol helps diagnose citrullinaemia type I in neonates. This method confirms diagnosis and predicts disease severity, identifying a common mutation in Pacific Island populations.
Area of Science:
- Biochemistry
- Genetics
- Newborn Screening
Background:
- Expanded newborn screening (E-NBS) identifies neonates with elevated citrulline.
- Citrullinaemia type I diagnosis requires confirmation, often through genetic analysis.
- The ASS1 gene is crucial for urea cycle function and citrulline metabolism.
Purpose of the Study:
- To develop and implement a mutation screening protocol for the ASS1 gene.
- To confirm diagnoses of citrullinaemia type I in neonates identified by E-NBS.
- To correlate ASS1 gene mutations with clinical presentation and disease severity.
Main Methods:
- Identified three neonates with elevated citrulline via E-NBS.
- Applied polymerase chain reaction (PCR) and sequencing to analyze the ASS1 gene.
- Utilized a rapid mutation-specific detection method and followed clinical progress.
Main Results:
- All three patients were homozygous for the missense mutation c.787G>A (p.Val263Met) in the ASS1 gene.
- This mutation is associated with a mild or asymptomatic clinical course.
- The same mutation was found in all patients, irrespective of non-consanguinity or Pacific Island origin.
Conclusions:
- Rapid ASS1 gene sequencing confirms citrullinaemia type I and helps infer phenotypic severity in screened neonates.
- The identified mutation (c.787G>A) may be prevalent in specific ethnic groups, suggesting a possible founder effect.
- This protocol aids in managing neonates with elevated citrulline detected through E-NBS.
Aim:
The aim of this study was to develop and apply a mutation screening protocol for the ASS1 gene in order to confirm the diagnosis of citrullinaemia type I in neonates with elevated citrulline on expanded newborn screening (E-NBS).
Methods:
Three patients with an elevated citrulline level were identified via routine E-NBS between January and October 2008. Analysis of the ASS1 gene using a polymerase chain reaction and sequencing-based method was successfully applied to all three patients, together with a rapid mutation-specific detection method. Their clinical progress was followed for 16-22 months.
Results:
All three patients were homozygous for a previously reported missense mutation, c.787G>A (p.Val263Met), associated with a mild or asymptomatic clinical course.
Conclusions:
As a consequence of E-NBS, an increasing number of neonates with elevated citrulline of uncertain clinical significance are being identified. Rapid sequence analysis of the ASS1 gene can be used to confirm citrullinaemia type I and, increasingly, to infer phenotypic severity. Homozygosity for the same mutation was found in all three patients despite non-consanguinity and variable Pacific Island origin. These data suggest that this mutation may be relatively prevalent in these ethnic groups and imply a possible founder effect.
Related Concept Videos
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Lethal Alleles
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Inborn Errors of Metabolism

